Publications

October 2008

alert: 2008 FTC Actions in the Drug Industry

An Annotated Summary
James B. Kobak, Jr.


As much as any one or even a series of court decisions, actions by the U.S. Federal Trade Commission shape the guidance given to brand-name drug manufacturers to ensure their compliance with antitrust law. What follows in this Alert are summaries of six FTC actions taken by the FTC so far in 2008, with brief discussions that seek to highlight their relevance to the industry.